These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 872010

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of 37 cases of tardive dyskinesia by deanol].
    Cai N.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):234-6. PubMed ID: 4075918
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study.
    de Montigny C, Chouinard G, Annable L.
    Psychopharmacology (Berl); 1979 Nov; 65(3):219-23. PubMed ID: 117492
    [Abstract] [Full Text] [Related]

  • 7. Deanol acetamidobenzoate treatment in choreiform movement disorders.
    Tarsy D, Bralower M.
    Arch Neurol; 1977 Dec; 34(12):756-8. PubMed ID: 145212
    [Abstract] [Full Text] [Related]

  • 8. Electromyographic assessment of dimethylaminoethanol (deanol) in treatment of tardive dyskinesia.
    Lonowski DJ, Sterling FE, King HA.
    Psychol Rep; 1979 Oct; 45(2):415-9. PubMed ID: 538170
    [No Abstract] [Full Text] [Related]

  • 9. Deanol acetamidobenzoate (Deaner) in tardive dyskinesia.
    Stafford JR, Fann WE.
    Dis Nerv Syst; 1977 Dec; 38(12 Pt 2):3-6. PubMed ID: 590063
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Deanol, lithium and placebo in the treatment of tardive dyskinesia. A double-blind crossover study.
    Jus A, Villeneuve A, Gautier J, Jus K, Villeneuve C, Pires P, Villeneuve R.
    Neuropsychobiology; 1978 Dec; 4(3):140-9. PubMed ID: 340975
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Deanol in the management of involuntary movement disorders: a review.
    Casey DE.
    Dis Nerv Syst; 1977 Dec; 38(12 Pt 2):7-15. PubMed ID: 145359
    [No Abstract] [Full Text] [Related]

  • 19. Deanol acetamidobenzoate inhibits the blood-brain barrier transport of choline.
    Millington WR, McCall AL, Wurtman RJ.
    Ann Neurol; 1978 Oct; 4(4):302-6. PubMed ID: 727735
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.